Pyridoxine 5’-phosphate oxidase

Pyridoxine 5’-phosphate oxidase

Name=Pyridoxine 5'-phosphate oxidase
Photo=Pyridoxin 5'-phosphate oxidase2.jpg
Type=Enzyme: Oxidoreductase
Functions=converts pyridoxine phosphate + oxygen to hydrogen peroxide+ pyridoxal phosphate and converts amine + water + oxygen to aldehyde + ammonia + hydrogen peroxide and converts pyridoxamine 5'-phosphate + water + oxygen to pyridoxal 5'-phosphate + ammonia + hydrogen peroxide
Cofactors=flavin mononucleotide
Pathways=Vitamin B6 metabolism, Nitrogen Metabolism
Names=pyridoxamine 5'-phosphate oxidase, pyridoxamine phosphate oxidase, pyridoxine (pyridoxamine)phosphate oxidase, pyridoxine (pyridoxamine) 5'-phosphate oxidase, pyridoxaminephosphate oxidase

Pyridoxine 5’-phosphate oxidase is an enzyme that catalyzes several reactions in the vitamin B6 metabolism pathway. Pyridoxine-5-P oxidase catalyzes the terminal step (also the rate-limiting step) in vitamin B6 metabolism, the biosynthesis of pyridoxal-5’-phosphate, the biologically active form of vitamin B6 which acts as an essential cofactor.cite web |url= |title=Vitamin B6 |accessdate=2007-06-03] Pyridoxine 5’-phosphate oxidase is a member of the enzyme class oxidases, or more specifically, oxidoreductases. These enzymes catalyze a simultaneous oxidation-reduction reaction. The substrate oxidase enzymes is hydroxlyated by one oxygen atom of molecular oxygen.cite book |author=David L. Nelson, Michael M. Cox, |title=Lehninger Principles of Biochemistry, Fourth Edition |publisher=W. H. Freeman and Company |location=New York |isbn=0-7167-4339-6] Concurrently, the other oxygen atom is reduced to water. Even though molecular oxygen is the electron acceptor in these enzymes’ reactions, they are unique because oxygen does not appear in the oxidized product.


Pyridoxine 5’-phosphate oxidase is a homodimer, or a molecule consisting of two identical polypeptide subunits. It is hypothesized that the two monomers are held together via disulfide bonds. There are also salt-bridge interactions between the two monomers. Each subunit tightly binds one molecule of pyridoxal 5'-phosphate tightly on each subunit. Both alpha-helices and beta-sheets are present in the protein motif, which is best described as a split-barrel structure. This structure is due, in part, to the disulfide bonds present in the secondary protein structure of this enzyme. Mutiple thiol groups (-SH) indicate the presence of disulfide bonds in the structure of the molecule. This enzyme requires the presence of a cofactor, FMN (flavin mononucleotide). OMIM|603287|PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE; PNPO] Cofactors are ions or coenzymes necessary for enzyme activity. The FMN is located in a deep cleft (formed by the two polypeptide subunits), and held in place by extensive hydrogen-bond interactions with the protein. In this particular case, the FMN helps the enzyme to bind the substrates. In the absence of pyridoxal 5’-phosphate (PLP), the active site of the enzyme is in an “open” conformation. Once substrate binds and is converted to PLP, the active site of the enzyme is in a partially “closed” conformation. Specific amino acid residues can form hydrogen bonds with the PLP, thus forming a lid that physically covers the active site, giving rise to the “closed” conformation.cite web |url= |title=RCSB PDB : “Active Site Structure of E. coli pyridoxine 5'-phosphate Oxidase” |accessdate=2007-06-03]


Pyridoxine 5’-phosphate oxidase is the enzyme that catalyzes the rate-limited step of the B6 metabolism pathway. Vitamin B6, which is also known as peroxidine, is a crucial nutrient for the human body, as it is responsible for more bodily functions that any other vitamin. Vitamin B6 is a coenzyme in the metabolism of carbohydrates, fats and proteins. This means that the enzymes which break these entities down for use in the body cannot function unless Vitamin B6 is present to induce a conformational change in the enzyme, thus activating it. Vitamin B6 also plays a role in the synthesis of hormones, red blood cells, neurotransmitters and enzymes. A person who is deficient in Vitamin B6 could suffer from insomnia, as well as suffer damage to the central nervous system.


Pyridoxine 5’-phosphate oxidase catalyzes several reactions; the two most important are the deamination of pyridoxamine-5'-phosphate and the deamination of pyridoxine 5-phosphate, both of which are key intermediates in the metabolism of B6. For a complete map of the B6 metabolism, Pyridoxine 5’-phosphate oxidase’s EC number is

pyridoxamine 5'-phosphate + H2O + O2 = pyridoxal 5'-phosphate + NH3 + H2O2

pyridoxine phosphate + oxygen <=> H2O2 + pyridoxal phosphate

Pyridoxine 5’-phosphate oxidase also plays a role in nitrogen metabolism, converting amines to aldehydes NH3 by the reaction: amine + H2O + oxygen <=> aldehyde + NH3 + H2O2


In humans, the pyridoxine 5’-phosphate oxidase enzyme exhibits a low catalytic rate constant of 0.2 sec-1, with low Km values for both pyridoxine 5'phosphate and pyridoxamine 5'-phosphate. The enzyme also has a low turnover rate, meaning that it is relatively slow converting substrate to product. Pyridoxal 5'-phosphate is an effective product inhibitor. Since pyridoxal 5'-phosphate, the active form of vitamin B6, is the product of the metabolic pathway, if it exists in excess, then the pathway need not proceed to keep making product. However, if it exists in low concentrations, then that is a signal for the pathway to synthesize more. This is an example of feedback inhibition.cite journal |author=Musayev FN, Di Salvo ML, Ko TP, Schirch V, Safo MK |title=Structure and properties of recombinant human pyridoxine 5'-phosphate oxidase |journal=Protein Sci. |volume=12 |issue=7 |pages=1455–63 |year=2003 |pmid=12824491 |doi=10.1110/ps.0356203]

Pyridoxine 5’-phosphate oxidase in different organisms

Pyridoxine 5’-phosphate oxidase has been highly conserved over time, as there are many similarities between the enzyme as it is found in humans and E. coli. Although there is only 39% retention of amino acid sequence from the E. coli version of the enzyme to the human version, the sequences for the FMN binding site and the substrate active sites are among the very highly conserved portion. One of the key differences is that the human pyridoxine 5’-phosphate oxidase has a higher specificity for the pyridoxamine-5'-phosphate substrate, whereas the pyridoxine 5’-phosphate oxidase in E. coli has a higher specificity pyridoxal-5’-phosphate substrate.


Wikimedia Foundation. 2010.

Look at other dictionaries:

  • Pyridoxine 4-oxidase — In enzymology, a pyridoxine 4 oxidase (EC number| is an enzyme that catalyzes the chemical reaction:pyridoxine + O2 ightleftharpoons pyridoxal + H2O2Thus, the two substrates of this enzyme are pyridoxine and O2, whereas its two products… …   Wikipedia

  • Copper deficiency — Classification and external resources ICD 10 E61.0 ICD 9 275.1 Copper deficiency is a very ra …   Wikipedia

  • List of biomolecules — This page aims to list articles on Wikipedia that describe particular biomolecules or types of biomolecules.This list is not necessarily complete or up to date if you see an article that should be here but isn t (or one that shouldn t be here but …   Wikipedia

  • Tuberculosis treatment — Various pharmaceutical tuberculosis treatments their actions Tuberculosis treatment refers to the medical treatment of the infectious disease tuberculosis (TB). The standard short course treatment for TB is isoniazid, rifampicin (also known as… …   Wikipedia

  • Homocysteine — chembox new ImageFile=Homocysteine racemic.png ImageSize=200px IUPACName=2 Amino 4 mercaptobutanoic acid OtherNames= Section1=Chembox Identifiers CASNo=454 29 5 PubChem=778 SMILES=C(CS)C(C(=O)O)N Section2=Chembox Properties Formula=C4H9NO2S… …   Wikipedia

  • Linezolid — drugbox IUPAC name = N [3 (3 fluoro 4 morpholinophenyl) 2 oxooxazolidin 5 yl] methyl] acetamide CAS number = 165800 03 3 ATC prefix = J01 ATC suffix = XX08 PubChem = 441401 DrugBank = APRD01073 C=16 | H=20 | F=1 | N=3 | O=4 molecular weight = 337 …   Wikipedia

  • Treatments of Parkinson's Disease — As Parkinson s disease is a chronic disorder, Treatment of Parkinson s Disease requires broad based management including patient and family education, support group services, general wellness maintenance, exercise, and nutrition. At present,… …   Wikipedia

  • therapeutics — /ther euh pyooh tiks/, n. (used with a sing. v.) the branch of medicine concerned with the remedial treatment of disease. [1665 75; see THERAPEUTIC, ICS] * * * Treatment and care to combat disease or alleviate pain or injury. Its tools include… …   Universalium

  • Ginkgo biloba — This article is about the tree. For the Goethe poem, see Gingo biloba. Ginkgo biloba Temporal range: 49.5–0 Ma …   Wikipedia

  • Hydrazine sulfate — IUPAC name Hydrazinium hydrogen sulfate …   Wikipedia